Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F JOLY

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapyP-A Bolze, B You, J-P Lotz, et al.
Gynecologic Oncology|October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 studyF Gernier, A Gompel, C Rousset-Jablonski, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2005
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)A Brédart, A Bottomley, J M Blazeby, et al.
ESMO Open|April 12, 2025
Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe studyS Quesada, A Puszkiel, A Jouinot, et al.
ESMO Open|February 13, 2024
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomesM A Franzoi, M Aupomerol, J Havas, et al.
ESMO Open|May 16, 2025
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)A-S Hamy, B Grandal, F Jochum, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2013
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG)D Querleu, I Ray-Coquard, J M Classe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countriesG Oskay-Özcelik, S Alavi, R Richter, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapyP-A Bolze, B You, J-P Lotz, et al.
Gynecologic Oncology|October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 studyF Gernier, A Gompel, C Rousset-Jablonski, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2005
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)A Brédart, A Bottomley, J M Blazeby, et al.
ESMO Open|April 12, 2025
Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe studyS Quesada, A Puszkiel, A Jouinot, et al.
ESMO Open|February 13, 2024
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomesM A Franzoi, M Aupomerol, J Havas, et al.
ESMO Open|May 16, 2025
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)A-S Hamy, B Grandal, F Jochum, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2013
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG)D Querleu, I Ray-Coquard, J M Classe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countriesG Oskay-Özcelik, S Alavi, R Richter, et al.
Pageof 17